Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App aims to improve tracking of rare paralysis attacks

NCT ID NCT05976958

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a smartphone app designed to help people with periodic paralysis record their muscle weakness episodes in real time. The goal was to see if the app could collect more accurate information about attacks compared to standard interviews during doctor visits. Only 2 people enrolled before the study was stopped early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
smartphone application
What this could lead to
If successful, this app could help doctors better understand and manage periodic paralysis by providing more accurate attack data.
What could go wrong
The study was terminated early with only 2 participants, so results are very limited and may not apply to others.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2 people

The number who actually took part.

Started

Jul 2019

Finished

Aug 2019

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients over 12 years of age with periodic paralyses, being followed at the Muscular Channelopathies Reference Center at the Pitié-Salpêtrière Hospital Group, who meet the inclusion criteria, are adequately informed, and have provided consent, may be enrolled in the study by their physician.

Ages

12 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: All patients with periodic paralysis aged over 12 years and followed in the National Channelopathies Reference Centre will be eligible for the study if they: are able to understand, read and write French are willing to and capable of entering their clinical and medico-social and economic data in the Smartphone application have an identified parent/caregiver for children aged 12-18 years (not mandatory for adults) are affiliated to a Health Insurance are able to give their informed consent (adult patients) or if their legal representatives are able to give their informed consent (child patients) Exclusion Criteria: Will not be eligible, patients with a condition that could explain hypokalemia: renal, adrenal, thyroid dysfunction, renal tubular acidosis, abuse of diuretic and laxative, with a condition that could explain hyperkalemia: renal, adrenal, thyroid dysfunction, use of potassium-sparing diuretics, who are under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periodic paralyses are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

periodic paralysis Rare Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • RaDiCo-PP

    Paris, Île-de-France Region, 75012, France